Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
Multiple Key Leadership Appointments, Including Warner Biddle as CEO, Bringing Clinical, Commercial and Strategic Expertise in Cell Therapy Continuing to Advance... Read more.
Blue Owl Technology Finance Corp. and Blue Owl Technology Finance Corp. II Announce Merger Agreement
Merger of two high-quality, diversified software-focused portfolios with substantial investment overlap significantly enhances scale Expected to create one of the... Read more.
Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
First patient dosed in randomized, Phase 2 study in presurgical triple negative breast cancer SHELTON, Conn., Nov. 13, 2024 /PRNewswire/ — Intensity Therapeutics,... Read more.
Kulicke & Soffa Reports Fourth Quarter 2024 Results
SINGAPORE, Nov. 13, 2024 /PRNewswire/ — Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) (“Kulicke & Soffa,” “K&S,” “our,”... Read more.
Itron and PG&E Collaborate to Enable Real-Time Control of Electric Vehicle Charging with Grid Edge Intelligence
Innovative EV Connect Program Makes EV Charging More Accessible and Affordable for Customers LIBERTY LAKE, Wash. and SAN JOSE, Calif., Nov. 13, 2024 /PRNewswire/... Read more.
Armata Pharmaceuticals Announces Third Quarter 2024 Results and Provides Corporate Update
LOS ANGELES, Nov. 13, 2024 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology... Read more.
Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Five sites actively screening with multiple patients having completed the study; two additional institutions expected to begin screening in the fourth quarter totaling... Read more.
Tyra Biosciences to Present at Upcoming Investor Conferences
CARLSBAD, Calif., Nov. 13, 2024 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation... Read more.
Kulicke & Soffa Expands Fluxless Thermo-Compression Customer Base
SINGAPORE, Nov. 13, 2024 /PRNewswire/ — Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) (“Kulicke & Soffa”, “K&S”, “we”... Read more.
DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update
– Seeking to initiate Phase 3 registrational trial for larsucosterol with topline results expected within two years of initiation – Webcast... Read more.